🇺🇸 Bifidobacterium infantis 35624 in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Coordination Abnormal — 1 report (10%)
  2. Drug Interaction — 1 report (10%)
  3. Fatigue — 1 report (10%)
  4. Frequent Bowel Movements — 1 report (10%)
  5. Headache — 1 report (10%)
  6. Muscle Injury — 1 report (10%)
  7. Muscle Spasms — 1 report (10%)
  8. Pain — 1 report (10%)
  9. Pollakiuria — 1 report (10%)
  10. Product Label Issue — 1 report (10%)

Source database →

Other Gastroenterology approved in United States

Frequently asked questions

Is Bifidobacterium infantis 35624 approved in United States?

Bifidobacterium infantis 35624 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Bifidobacterium infantis 35624 in United States?

Procter and Gamble is the originator. The local marketing authorisation holder may differ — check the official source linked above.